Ontogeny of Salivary Epidermal Growth Factor and Necrotizing Enterocolitis

Journal of Pediatrics

Volumn 150, Issue 4, 2007, Pages 358-363

  Warner, Barbara B ^a   Ryan, Ann Ladd ^a   Seeger, Kimberly ^a   Leonard, Anthony C ^a   Erwin, Christopher R ^a   Warner, Brad W ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR;

ARTICLE; CLINICAL ARTICLE; DRUG SALIVA LEVEL; FEMALE; FOLLOW UP; GESTATIONAL AGE; HUMAN; INFANT; LIFE; LOW BIRTH WEIGHT; MALE; MULTIVARIATE ANALYSIS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NECROTIZING ENTEROCOLITIS; ONTOGENY; PERINATAL PERIOD; PREDICTOR VARIABLE; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE; STATISTICAL SIGNIFICANCE;

AGE FACTORS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APGAR SCORE; COHORT STUDIES; CONTINENTAL POPULATION GROUPS; ENTEROCOLITIS, NECROTIZING; EPIDERMAL GROWTH FACTOR; FEMALE; GESTATIONAL AGE; HUMANS; INDOMETHACIN; INFANT FORMULA; INFANT, NEWBORN; INFANT, PREMATURE; MALE; MILK, HUMAN; MULTIVARIATE ANALYSIS; ODDS RATIO; OHIO; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; SALIVA;

EID: 33947211314     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2006.11.059     Document Type: Article

References (45)

1. Kosloske A.M. Epidemiology of necrotizing enterocolitis. Acta Paediatr Suppl 396 (1994) 2-7
2. Kliegman R.M. Neonatal necrotizing enterocolitis: bridging the basic science with the clinical disease. J Pediatr 117 (1990) 833-835
3. Holman R.C., Stoll B.J., Clarke M.J., and Glass R.I. The epidemiology of necrotizing enterocolitis infant mortality in the United States. Am J Public Health 87 (1997) 2026-2031
4. Playford R.J., Hanby A.M., Gschmeissner S., Peiffer L.P., Wright N.A., and McGarrity T. The epidermal growth factor receptor (EGF-R) is present on the basolateral, but not the apical, surface of enterocytes in the human gastrointestinal tract. Gut 39 (1996) 262-266
5. Wong W.M., and Wright N.A. Epidermal growth factor, epidermal growth factor receptors, intestinal growth, and adaptation. JPEN J Parenter Enteral Nutr 23 (1999) S83-S88
6. Menard D., and Pothier P. Radioautographic localization of epidermal growth factor receptors in human fetal gut. Gastroenterology 101 (1991) 640-649
7. Buchmiller T.L., Shaw K.S., Chopourian H.L., Lloyd K.C., Gregg J.P., Rivera Jr. F.A., et al. Effect of transamniotic administration of epidermal growth factor on fetal rabbit small intestinal nutrient transport and disaccharidase development. J Pediatr Surg 28 (1993) 1239-1244
8. Read L.C., Tarantal A., and George-Nascimento C. Effects of recombinant human epidermal growth factor on the intestinal growth of fetal rhesus monkeys. Acta Paediatr Scand Suppl 351 (1989) 97-103
9. Miettinen P.J., Berger J.E., Meneses J., Phung Y., Pedersen R.A., Werb Z., et al. Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature 376 (1995) 337-341
10. Hirai C., Ichiba H., Saito M., Shintaku H., Yamano T., and Kusuda S. Trophic effect of multiple growth factors in amniotic fluid or human milk on cultured human fetal small intestinal cells. J Pediatr Gastroenterol Nutr 34 (2002) 524-528
11. Li A.K., Schattenkerk M.E., Huffman R.G., Ross J.S., and Malt R.A. Hypersecretion of submandibular saliva in male mice: trophic response in small intestine. Gastroenterology 84 (1983) 949-955
12. Rao R.K., Thomas D.W., Pepperl S., and Porreca F. Salivary epidermal growth factor plays a role in protection of ileal mucosal integrity. Dig Dis Sci 42 (1997) 2175-2181
13. Olsen P.S., Poulsen S.S., Kirkegaard P., and Nexo E. Role of submandibular saliva and epidermal growth factor in gastric cytoprotection. Gastroenterology 87 (1984) 103-108
14. Lipscomb G.R., Painter J., Riley S., Gillott T., and Rees W. Role of acid and salivary epidermal growth factor in gastric mucosal adaptation to naproxen in man. Scand J Gastroenterol 33 (1998) 790-794
15. Evans N.J., Rutter N., and Gregory H. Urinary excretion of epidermal growth factor in the newborn. Early Hum Devel 14 (1986) 277-282
16. Scott S.M., Guardian C.M., Angelus P., and Backstrom C. Developmental pattern of urinary epidermal growth factor in the premature infant and the influence of gender. J Clin Endocrinol Metab 72 (1991) 588-593
17. Tsau Y.K., Teng R.J., and Chen C.H. Correlation between urinary epidermal growth factor excretion and serum thyroid hormone in premature and term neonates. Nephron 78 (1998) 168-171
18. Watanabe K., Ono A., Hirata Y., Fukuda Y., Kojima T., and Kobayashi Y. Maturational changes and origin of urinary human epidermal growth factor in the neonatal period. Biol Neonate 56 (1989) 241-245
19. Ichiba H., Fujimura M., and Takeuchi T. Levels of epidermal growth factor in human cord blood. Biol Neonate 61 (1992) 302-307
20. Scott S.M., Buenaflor G.G., and Orth D.N. Immunoreactive human epidermal growth factor concentrations in amniotic fluid, umbilical artery and vein serum, and placenta in full-term and preterm infants. Biol Neonate 56 (1989) 246-251
21. Bell M.J., Ternberg J.L., Feigin R.D., Keating J.P., Marshall R., Barton L., et al. Neonatal necrotizing enterocolitis: therapeutic decisions based upon clinical staging. Ann Surg 187 (1978) 1-7
22. Helmrath M.A., Shin C.E., Fox J.W., Erwin C.R., and Warner B.W. Epidermal growth factor in saliva and serum of infants with necrotising enterocolitis. Lancet 24 (1998) 266-267
23. Shin C.E., Falcone Jr. R.A., Stuart L., Erwin C.R., and Warner B.W. Diminished epidermal growth factor levels in infants with necrotizing enterocolitis. J Pediatr Surg 35 (2000) 173-176
24. Grunau R.E., Weinberg J., and Whitfield M.F. Neonatal procedural pain and preterm infant cortisol response to novelty at 8 months. Pediatrics 114 (2004) e77-e84
25. Ruhl S., Rayment G., Schmalz k., Hiller A., and Troxler R. Proteins in whole saliva during the first year of infancy. J Dent Res 84 (2005) 29-34
26. Scott S.M., Rogers C., and Backstrom C. Dexamethasone therapy is associated with a rise in urinary epidermal growth factor concentrations in the preterm infant. Eur J Endocrinol 132 (1995) 326-330
27. Shigeta K., Hiramatsu Y., Eguchi K., and Sekiba K. Urinary and plasma epidermal growth factor levels are decreased in neonates with intrauterine growth retardation and in their mothers. Biol Neonate 62 (1992) 76-82
28. Gale S.M., Read L.C., George-Nascimento C., Wallace J.C., and Ballard F.J. Is dietary epidermal growth factor absorbed by premature human infants?. Biol Neonate 55 (1989) 104-110
29. Dvorak B., Fituch C.C., Williams C.S., Hurst N.M., and Schanler R.J. Increased epidermal growth factor levels in human milk of mothers with extremely premature infants. Pediatr Res 54 (2003) 15-19
30. Dvorak B., Halpern M.D., Holubec H., Williams C.S., McWilliam D.L., Dominguez J.A., et al. Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal rat model. Am J Physiol Gastrointest Liver Physiol 282 (2002) G156-G164
31. Clark J.A., Lane R.H., Maclennan N.K., Holubec H., Dvorakova K., Halpern M.D., et al. Epidermal growth factor reduces intestinal apoptosis in an experimental model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 288 (2005) G755-G762
32. Okuyama H., Urao M., Lee D., Drongowski R.A., and Coran A.G. The effect of epidermal growth factor on bacterial translocation in newborn rabbits. J Pediatr Surg 33 (1998) 225-228
33. McAndrew H.F., Lloyd D.A., Rintala R., and van Saene H.K. The effects of intravenous epidermal growth factor on bacterial translocation and central venous catheter infection in the rat total parenteral nutrition model. Pediatr Surg Int 16 (2000) 169-173
34. Zapata-Sirvent R.L., Hansbrough J.F., Wolf P., Grayson L.S., and Nicolson M. Epidermal growth factor limits structural alterations in gastrointestinal tissues and decreases bacterial translocation in burned mice. Surgery 113 (1993) 564-573
35. Claud E.C., and Walker W.A. Hypothesis: inappropriate colonization of the premature intestine can cause neonatal necrotizing enterocolitis. FASEB J 15 (2001) 1398-1403
36. Caplan M.S., and Jilling T. New concepts in necrotizing enterocolitis. Curr Opin Pediatr 13 (2001) 111-115
37. Sullivan P.B., Lewindon P.J., Oppenheimer S.J., Cheng C., Goodlad R.A., and Wright N.A. A pilot study of the safety and efficacy of epidermal growth factor (rEGF) in the treatment of severe necrotizing enterocolitis. Gut 41 (1997) A69
38. Sullivan P.B., Brueton M.J., Tabara Z.B., Goodlad R.A., Lee C.Y., and Wright N.A. Epidermal growth factor in necrotizing enteritis. Lancet 338 (1991) 53-54
39. Scott S., Rogers C., Angelus P., and Backstorm C. Effect of necrotizing enterocolitis on urinary epidermal growth factor levels. AJDC 145 (1991) 804-807
40. Wright N.A., Pike C., and Elia G. Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cells. Nature 343 (1990) 82-85
41. Guthrie S.O., Gordon P.V., Thomas V., Thorp J.A., Peabody J., Clark R.H., et al. Necrotizing enterocolitis among neonates in the United States. J Perinatol 23 (2003) 278-285
42. Llanos A.R., Moss M.E., Pinzon M.C., Dye T., Sinkin R.A., Kendig J.W., et al. Epidemiology of neonatal necrotising enterocolitis: a population based study. Paediatr Perinat Epidemiol 16 (2002) 342-349
43. Uauy R.D., Fanaroff A.A., Korones S.B., Phillips E.A., Phillips J.B., Wright L.L., et al. Necrotizing enterocolitis in very low birth weight infants: biodemographic and clinical correlates. J Pediatr 119 (1991) 630-638
44. Warner B.W., Vanderhoof J.A., and Reyes J.D. What's new in the management of short gut syndrome in children. J Am Coll Surg 190 (2000) 725-736
45. Warner B.W., and Ziegler M.M. Management of the short bowel syndrome in the pediatric population. Pediatr Clin North Am 40 (1993) 1335-1350